• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Andrea Eleazar, MHS

home / authors / andrea-eleazar-mhs

Andrea Eleazar, MHS, is an assistant editor for Targeted Oncology, with interests in noncommunicable diseases, health equity research, and global health. Eleazar holds a Master of Health Science in Epidemiology from the Johns Hopkins Bloomberg School of Public Health, as well as a BS in Public Health and certificate in Writing & Publishing from Drexel University.

Articles

3D-rendered image of too many white blood cells due to leukemia | Image credit: Sebastian Kaulitzki - stock.adobe.com

Olutasidenib’s 5-Year Data Confirm Durability and Safety in mIDH1 AML

December 1st 2025

Olutasidenib shows promising long-term efficacy and safety in treating relapsed or refractory mutant IDH1 acute myeloid leukemia.

Multiple myeloma | Image Credit: © angellodeco-stock.adobe.com

BMI in CAR T: Overweight Status Predicts Worse MM Outcomes

November 29th 2025

A study reveals a U-shaped relationship between BMI and CAR T-cell therapy outcomes in multiple myeloma (MM), highlighting the impact of overweight status on efficacy.

© 2026 MJH Life Sciences
AJMC®
All rights reserved.